There are 2789 resources available
1215P - EGFR-mutated squamous cell lung cancer and its association with outcomes
Presenter: Yang Xia
Session: ePoster Display
1216P - Effectiveness of osimertinib plus chemotherapy and avastin for EGFR-mutated advanced non-small cell lung cancer with brain metastases
Presenter: Haifeng Qin
Session: ePoster Display
1217P - EGFR TKIs in patients (pts) with NSCLC with uncommon EGFR mutations: A real-world cohort study (UpSwinG)
Presenter: Satoru Miura
Session: ePoster Display
1219P - Study of anlotinib combined with icotinib as the first-line treatment in NSCLC patients harboring activating EGFR mutations: Updated results of ALTER-L004
Presenter: Dingzhi Huang
Session: ePoster Display
1220P - A randomized phase II trial of anlotinib plus docetaxel vs docetaxel for second-line treatment of EGFR-negative NSCLC (ALTER-L018)
Presenter: Lin Wu
Session: ePoster Display
1180P - Anlotinib combined with radiotherapy in locally advanced non-small cell lung cancer (LANSCLC): A prospective, single-arm, phase II study
Presenter: Peng Ning
Session: ePoster Display
1145P - Reliable detection of BRCA1 and BRCA2 large genomic rearrangements in FFPE tissue: A new diagnostic benchmark for somatic BRCA testing
Presenter: Nadejda Valtcheva
Session: ePoster Display
1146P - Closing the target gap: A computational approach to optimizing therapeutic selection for cancer patients
Presenter: Mikhail Grushko
Session: ePoster Display
1147P - AI-based detection of molecular biomarkers directly from H&E scanned slide
Presenter: Nir Peled
Session: ePoster Display